Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Biopharmaceutical production technology [[electronic resource] /] / edited by Ganapathy Subramanian
| Biopharmaceutical production technology [[electronic resource] /] / edited by Ganapathy Subramanian |
| Pubbl/distr/stampa | Weinheim, : Wiley-VCH Verlag GmbH & Co. KGaA, c2012 |
| Descrizione fisica | 1 online resource (915 p.) |
| Disciplina | 615.19 |
| Altri autori (Persone) | SubramanianGanapathy |
| Soggetto topico | Pharmaceutical biotechnology |
| ISBN |
3-527-65311-2
3-527-65309-0 1-280-67928-X 9786613656216 3-527-65312-0 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | v. 1, pt. 1. Upstream technologies ; pt. 2. Protein recovery ; pt. 3. Advances in process development -- v. 2, pt. 4. Analytical technologies ; pt. 5. Quality control ; pt. 6. Process design and management ; pt. 7. Changing face of processing. |
| Record Nr. | UNINA-9910139749903321 |
| Weinheim, : Wiley-VCH Verlag GmbH & Co. KGaA, c2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Biopharmaceutical production technology / / edited by Ganapathy Subramanian
| Biopharmaceutical production technology / / edited by Ganapathy Subramanian |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Weinheim, : Wiley-VCH Verlag GmbH & Co. KGaA, c2012 |
| Descrizione fisica | 1 online resource (915 p.) |
| Disciplina | 615.19 |
| Altri autori (Persone) | SubramanianGanapathy |
| Soggetto topico | Pharmaceutical biotechnology |
| ISBN |
3-527-65311-2
3-527-65309-0 1-280-67928-X 9786613656216 3-527-65312-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | v. 1, pt. 1. Upstream technologies ; pt. 2. Protein recovery ; pt. 3. Advances in process development -- v. 2, pt. 4. Analytical technologies ; pt. 5. Quality control ; pt. 6. Process design and management ; pt. 7. Changing face of processing. |
| Record Nr. | UNINA-9910815404603321 |
| Weinheim, : Wiley-VCH Verlag GmbH & Co. KGaA, c2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Continuous biomanufacturing : innovative technologies and methods / / edited by Ganapathy Subramanian
| Continuous biomanufacturing : innovative technologies and methods / / edited by Ganapathy Subramanian |
| Pubbl/distr/stampa | Weinheim, Germany : , : Wiley-VCH, , [2018] |
| Descrizione fisica | 1 online resource (631 pages) : color illustrations |
| Soggetto topico |
Pharmaceutical industry
Drugs - Research Drugs - Prices |
| ISBN |
3-527-69991-0
3-527-69989-9 3-527-69990-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910270910303321 |
| Weinheim, Germany : , : Wiley-VCH, , [2018] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Continuous biomanufacturing : innovative technologies and methods / / edited by Ganapathy Subramanian
| Continuous biomanufacturing : innovative technologies and methods / / edited by Ganapathy Subramanian |
| Pubbl/distr/stampa | Weinheim, Germany : , : Wiley-VCH, , [2018] |
| Descrizione fisica | 1 online resource (631 pages) : color illustrations |
| Soggetto topico |
Pharmaceutical industry
Drugs - Research Drugs - Prices |
| ISBN |
3-527-69991-0
3-527-69989-9 3-527-69990-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910822188803321 |
| Weinheim, Germany : , : Wiley-VCH, , [2018] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Continuous processing in pharmaceutical manufacturing / / edited by Ganapathy Subramanian
| Continuous processing in pharmaceutical manufacturing / / edited by Ganapathy Subramanian |
| Pubbl/distr/stampa | Weinheim, Germany : , : Wiley-VCH Verlag GmbH & Co. KGaA, , 2015 |
| Descrizione fisica | 1 online resource (531 p.) |
| Disciplina | 338.4561615 |
| Soggetto topico |
Pharmaceutical industry - Quality control
Pharmaceutical industry - Research |
| ISBN |
3-527-67370-9
3-527-67368-7 3-527-67371-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Continuous Processing in Pharmaceutical Manufacturing; Contents; List of Contributors; Preface; 1. Proteins Separation and Purification by Expanded Bed Adsorption and Simulated Moving Bed Technology; 1.1 Introduction; 1.2 Protein Capture by Expanded Bed Technology; 1.2.1 Adsorbent Materials; 1.2.2 Expanded Bed Adsorption/Desorption of Protein; 1.2.3 Modeling of the Expanded Bed; 1.3 Proteins Separation and Purification by Salt Gradient Ion Exchange SMB; 1.3.1 Adsorption Isotherms and Kinetics of BSA and Myoglobin on Ion Exchange Resins
1.3.2 Salt Gradient Formation and Process Design for IE-SMB Chromatography1.3.3 Separation Region of Salt Gradient IE-SMB Chromatography; 1.3.4 Proteins Separation and Purification in Salt Gradient IE-SMB with Open Loop Configuration; 1.4 Conclusion; References; 2. BioSMB Technology as an Enabler for a Fully Continuous Disposable Biomanufacturing Platform; 2.1 Introduction; 2.2 Integrated Continuous Bioprocessing; 2.3 Multicolumn Chromatography; 2.4 BioSMB Technology; 2.5 Fully Disposable Continuous Processing; 2.6 Case Studies; 2.7 Regulatory Aspects; 2.8 Conclusions; References 3. Impact of Continuous Processing Techniques on Biologics Supply Chains3.1 Introduction; 3.1.1 The Biologics Industry; 3.1.2 The Biologics Value Chain; 3.1.3 Downstream Purification Costs; 3.2 Chromatography Techniques Used in Downstream Purification of Biomolecules; 3.2.1 Need for Continuous Manufacturing in Downstream Purification; 3.2.2 The Multicolumn Countercurrent Solvent Gradient Purification Chromatography System; 3.3 Next-Generation Biologic Products - Bispecific Monoclonal Antibodies; 3.3.1 Major Biopharma Companies and Their Interest in Bispecific Mabs 3.3.2 Challenges in Purification of Bispecific Monoclonal Antibodies3.4 Improving the Downstream Processing of Bispecific Mabs by Introduction of MCSGP in the Value Chain; 3.4.1 Advantages of Utilizing MCSGP Process in Bispecific Mabs Purification as Compared to Batch Chromatography; 3.4.2 Impact of MCSGP System on Biologic Supply Chains; 3.4.3 Impact on Patent Approval Structure of Biologic Drugs; 3.4.3.1 For a Manufacturer Who Already has a Biologic Drug in the Market; 3.4.3.2 For a Manufacturer Who is Developing a Biologic Drug; 3.4.4 Impact on Big Biopharma Companies 3.4.5 Impact on the Chromatography Market3.4.6 Limitations of the MCSGP System; 3.5 Conclusion; 3.6 Further Research; Acknowledgments; 3.A Appendix/Additional Information; 3.A.1 Regulatory Structure for Bispecific Monoclonal Antibodies; 3.A.1.1 Regulatory Compliance Comparison between US, EU, and Emerging Economies; References; 4. Integrating Continuous and Single-Use Methods to Establish a New Downstream Processing Platform for Monoclonal Antibodies; 4.1 Introduction; 4.2 Harvest and Clarification; 4.2.1 The Challenge and Technology Selection; 4.2.1.1 Centrifugation; 4.2.1.2 Filtration 4.2.1.3 Impurity Precipitation |
| Record Nr. | UNINA-9910140481503321 |
| Weinheim, Germany : , : Wiley-VCH Verlag GmbH & Co. KGaA, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||